-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KrM9lv3kqFg2fGlKhCU19LhPXVztsElJ5d6VqY0iBVSMzVLBSLOsLftua9ZvZvJ3 hRDmyf7JkSRptIYD0wy5gA== 0001179110-06-002771.txt : 20060203 0001179110-06-002771.hdr.sgml : 20060203 20060203132020 ACCESSION NUMBER: 0001179110-06-002771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060202 FILED AS OF DATE: 20060203 DATE AS OF CHANGE: 20060203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REILLY PHILIP R CENTRAL INDEX KEY: 0001237194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 06576750 MAIL ADDRESS: STREET 1: C/O INTERLEUKIN GENETICS INC STREET 2: 135 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 4 1 edgar.xml FORM 4 - X0202 4 2006-02-02 0 0001037649 INTERLEUKIN GENETICS INC ILI 0001237194 REILLY PHILIP R 135 BEAVER STREET WALTHAM MA 02452 1 1 0 0 Chief Executive Officer Common Stock 2006-02-02 4 M 0 25000 2.50 A 35000 D Common Stock 73275 I See Footnote Warrants to Buy 2.50 2002-08-09 2012-08-09 Common Stock 25000 0 D The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purposes. Philip R. Reilly 2006-02-03 -----END PRIVACY-ENHANCED MESSAGE-----